Published in Cell Cycle on June 15, 2010
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response. Oncotarget (2012) 1.85
Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis. Neurosci Lett (2011) 1.12
Advances in targeting signal transduction pathways. Oncotarget (2012) 1.06
Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in rat. Epilepsia (2012) 1.01
Fetal brain mTOR signaling activation in tuberous sclerosis complex. Cereb Cortex (2012) 0.98
Spatiotemporal characterization of mTOR kinase activity following kainic acid induced status epilepticus and analysis of rat brain response to chronic rapamycin treatment. PLoS One (2013) 0.88
Rapamycin has paradoxical effects on S6 phosphorylation in rats with and without seizures. Epilepsia (2012) 0.84
Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease. Acta Neuropathol Commun (2013) 0.82
Rapamycin for treatment of epilepsy: antiseizure, antiepileptogenic, both, or neither? Epilepsy Curr (2011) 0.82
Seizure-induced reduction in PIP3 levels contributes to seizure-activity and is rescued by valproic acid. Neurobiol Dis (2013) 0.82
Gene expression profiling of a hypoxic seizure model of epilepsy suggests a role for mTOR and Wnt signaling in epileptogenesis. PLoS One (2013) 0.82
The expanding relevance of nuclear mTOR in carcinogenesis. Cell Cycle (2011) 0.81
Before epilepsy unfolds: finding the epileptogenesis switch. Nat Med (2012) 0.81
Caloric restriction protects against electrical kindling of the amygdala by inhibiting the mTOR signaling pathway. Front Cell Neurosci (2015) 0.76
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol (2002) 17.41
Growing roles for the mTOR pathway. Curr Opin Cell Biol (2005) 11.66
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell (2002) 11.65
Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell (1992) 8.51
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev (2002) 8.31
RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc Natl Acad Sci U S A (1998) 8.03
The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J (2008) 6.32
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol (2008) 5.55
AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem (2002) 3.81
The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci (2009) 3.80
Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci (2008) 3.64
Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci (2009) 2.90
mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo. Proc Natl Acad Sci U S A (2003) 2.68
Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia (2001) 2.63
A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells (2003) 2.62
Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov Today (2006) 2.59
Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies. Epilepsia (2009) 1.98
Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis Model Mech (2009) 1.87
Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis (2007) 1.86
Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy. J Neurosci (2009) 1.85
Mammalian target of rapamycin (mTOR): pro- and anti-apoptotic. Cell Death Differ (2002) 1.64
Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc Natl Acad Sci U S A (1998) 1.59
mTOR: a protein kinase switching between life and death. Pharmacol Res (2004) 1.55
New Horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res (2006) 1.32
Alterations in mammalian target of rapamycin signaling pathways after traumatic brain injury. J Cereb Blood Flow Metab (2006) 1.23
Mammalian target of rapamycin: master regulator of cell growth in the nervous system. Histol Histopathol (2007) 1.22
The upregulation of p27Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines. Blood (1998) 1.22
Activity-dependent NMDA receptor-mediated activation of protein kinase B/Akt in cortical neuronal cultures. J Neurochem (2002) 1.13
Epileptogenesis and rational therapeutic strategies. Acta Neurol Scand (2006) 0.97
The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1. Lab Invest (2004) 0.93
Models of epileptogenesis in adult animals available for antiepileptogenesis drug screening. Epilepsy Res (2006) 0.91
Co-activation of the phosphatidylinositol-3-kinase/Akt signaling pathway by N-methyl-D-aspartate and TrkB receptors in cerebellar granule cell neurons. Amino Acids (2002) 0.90
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol (2008) 5.55
Corridors of migrating neurons in the human brain and their decline during infancy. Nature (2011) 4.12
The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci (2009) 3.80
Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol (2002) 3.37
Witness for Wellness: preliminary findings from a community-academic participatory research mental health initiative. Ethn Dis (2006) 2.38
A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons. Cell (2009) 2.21
Blood pressure and heart rate response to posteriorly directed pressure applied to the cervical spine in young, pain-free individuals: a randomized, repeated-measures, double-blind, placebo-controlled study. J Orthop Sports Phys Ther (2014) 1.98
Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14. Neuron (2002) 1.91
Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiol Dis (2006) 1.69
CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis. Mol Ther (2005) 1.66
Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Hum Mol Genet (2010) 1.53
Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes. Epilepsia (2005) 1.48
Abundance and isotopic composition of gases in the martian atmosphere from the Curiosity rover. Science (2013) 1.47
FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons. Neurobiol Dis (2008) 1.43
The evolution of display technologies in PACS applications. Comput Med Imaging Graph (2003) 1.43
Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex. Neurobiol Dis (2007) 1.37
Talking Wellness: a description of a community-academic partnered project to engage an African-American community around depression through the use of poetry, film, and photography. Ethn Dis (2006) 1.36
The natural history and treatment of epilepsy in a murine model of tuberous sclerosis. Epilepsia (2007) 1.26
Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents. J Clin Invest (2008) 1.23
Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men. Clin Infect Dis (2009) 1.22
Rapamycin attenuates the development of posttraumatic epilepsy in a mouse model of traumatic brain injury. PLoS One (2013) 1.16
Transient decrease in F-actin may be necessary for translocation of proteins into dendritic spines. Eur J Neurosci (2005) 1.15
The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia (2011) 1.14
Fetal alcohol exposure impairs alveolar macrophage function via decreased glutathione availability. Pediatr Res (2004) 1.13
Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis. Neurosci Lett (2011) 1.12
Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution? Infect Control Hosp Epidemiol (2008) 1.11
Mammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptogenic, and epileptostatic therapy. Curr Neurol Neurosci Rep (2012) 1.09
In vivo imaging of dendritic spines during electrographic seizures. Ann Neurol (2005) 1.02
Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex. Neurobiol Dis (2010) 1.01
Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in rat. Epilepsia (2012) 1.01
Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex. Neurobiol Dis (2009) 0.99
Transcriptional regulation of the homeobox gene Mixl1 by TGF-beta and FoxH1. Biochem Biophys Res Commun (2005) 0.98
Acute intermittent porphyria: a diagnostic challenge. J Child Neurol (2011) 0.97
Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (calcitriol) in combination with dexamethasone for castration-resistant prostate cancer. Cancer (2010) 0.97
Disruption of CK2beta in embryonic neural stem cells compromises proliferation and oligodendrogenesis in the mouse telencephalon. Mol Cell Biol (2010) 0.93
HIV/hepatitis C virus-coinfected patients and cirrhosis: how to diagnose it and what to do next? Clin Infect Dis (2013) 0.93
How significant are clinically insignificant residual fragments following lithotripsy? Curr Opin Urol (2005) 0.91
Evaluation of the effect of treatment of latent tuberculosis infection on QuantiFERON-TB gold assay results. Infect Control Hosp Epidemiol (2009) 0.90
Increased severity of pentylenetetrazol induced seizures in leptin deficient ob/ob mice. Neurosci Lett (2007) 0.90
Brief seizures cause dendritic injury. Neurobiol Dis (2011) 0.90
Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex. Am J Pathol (2010) 0.90
The utility of tuberless models of tuberous sclerosis. Epilepsia (2007) 0.89
A search for guidance: examining prenatal substance exposure protocols. Matern Child Health J (2002) 0.87
A Tactile Automated Passive-Finger Stimulator (TAPS). J Vis Exp (2009) 0.87
ENU-induced mutation in the DNA-binding domain of KLF3 reveals important roles for KLF3 in cardiovascular development and function in mice. PLoS Genet (2013) 0.87
Hyperbaric oxygen therapy for radiation-induced cystitis and proctitis. Int J Radiat Oncol Biol Phys (2012) 0.87
Rhein, a natural anthraquinone derivative, attenuates the activation of pancreatic stellate cells and ameliorates pancreatic fibrosis in mice with experimental chronic pancreatitis. PLoS One (2013) 0.86
Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex. PLoS One (2013) 0.86
Rapamycin has paradoxical effects on S6 phosphorylation in rats with and without seizures. Epilepsia (2012) 0.84
Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agents. Melanoma Res (2007) 0.84
AVI-7288 for Marburg Virus in Nonhuman Primates and Humans. N Engl J Med (2015) 0.83
Inhibitory effect of the gallotannin corilagin on dextran sulfate sodium-induced murine ulcerative colitis. J Nat Prod (2013) 0.82
Validity and reliability of the expectations regarding aging (ERA-12) instrument among middle-aged Singaporeans. Ann Acad Med Singapore (2010) 0.82
Rapamycin for treatment of epilepsy: antiseizure, antiepileptogenic, both, or neither? Epilepsy Curr (2011) 0.82
Is focal cortical dysplasia an infectious disease? Epilepsy Curr (2013) 0.81
Validation of the Chinese version of the Mood Disorder Questionnaire in a psychiatric population in Hong Kong. Psychiatry Clin Neurosci (2008) 0.81
Post-transplant aspergillosis and the role of combined neurosurgical and antifungal therapies under belatacept immunosuppression. Surg Neurol Int (2011) 0.81
Hippocampal seizures cause depolymerization of filamentous actin in neurons independent of acute morphological changes. Brain Res (2007) 0.81
Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway. Mol Cell Pharmacol (2009) 0.80
mTOR inhibition in epilepsy: rationale and clinical perspectives. CNS Drugs (2015) 0.80
Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures. Neuropsychiatr Dis Treat (2011) 0.80
Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy. Drug Healthc Patient Saf (2012) 0.80
Desmoplastic small round cell tumor (DSRCT) with ovarian involvement in 2 young women. Appl Immunohistochem Mol Morphol (2008) 0.79
Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting. Cardiovasc Revasc Med (2007) 0.78
Correspondence on ''effect of acupuncture on the brain in children with spastic cerebral palsy using functional neuroimaging (fMRI)''. J Child Neurol (2009) 0.78
Analysis of cerebrospinal fluid glial fibrillary acidic protein after seizures in children. Epilepsia (2003) 0.78
Burn healing is dependent on burn site: a quantitative analysis from a porcine burn model. Burns (2008) 0.78
A new derivatization method coupled with LC-MS/MS to enable baseline separation and quantification of dimethylarginines in human plasma from patients to receive on-pump CABG surgery. Electrophoresis (2012) 0.77
Secondary symptomatic parvovirus B19 infection in a healthy adult. J Gen Intern Med (2007) 0.77
Cutaneous head and neck melanoma: the old and the new. Expert Rev Anticancer Ther (2008) 0.77
Tumors generate excitement: the role of glutamate in tumor-related epilepsy. Epilepsy Curr (2012) 0.77
The effects of Boehmeria nivea (L.) Gaud. on embryonic development: in vivo and in vitro studies. J Ethnopharmacol (2010) 0.77
Quantitative longitudinal analysis of T cell receptor repertoire expression in HIV-infected patients on antiretroviral and interleukin-2 therapy. AIDS Res Hum Retroviruses (2007) 0.77
Epilepsy in a dish: an in vitro model of epileptogenesis. Epilepsy Curr (2011) 0.76
Local control and visual acuity following treatment of medium-sized ocular melanoma using a contact eye plaque: a single surgeon experience. Brachytherapy (2010) 0.76
A simple and robust LC-MS/MS method for quantification of free 3-nitrotyrosine in human plasma from patients receiving on-pump CABG surgery. Electrophoresis (2012) 0.76
mTOR Strikes Again: mTORC1 Activation Causes Epilepsy Independent of Overt Pathological Changes. Epilepsy Curr (2014) 0.76
Tuber-Less Models of Tuberous Sclerosis Still Provide Insights Into Epilepsy. Epilepsy Curr (2015) 0.76
A Tuber-ful Animal Model of Tuberous Sclerosis At Last? Epilepsy Curr (2012) 0.76
Management of difficult kidney stones. J Endourol (2007) 0.75
Shining light on epilepsy: optical approaches for treating seizures. Epilepsy Curr (2013) 0.75
Too much inhibition leads to excitation in absence epilepsy. Epilepsy Curr (2010) 0.75
Self-similarity of phase-space networks of frustrated spin models and lattice gas models. Phys Rev E Stat Nonlin Soft Matter Phys (2011) 0.75
"TOR"-ing Down the Dentate Gate in Temporal Lobe Epilepsy. Epilepsy Curr (2013) 0.75
Juvenile myoclonic epilepsy: is it an idiopathic epilepsy caused by a malformation of cortical development? Epilepsy Curr (2010) 0.75
Cortical interneurons join the mix in absence seizures. Epilepsy Curr (2014) 0.75
Herbs and spices: unexpected sources of antiepileptogenic drug treatments? Epilepsy Curr (2010) 0.75
Degrading epilepsy: the role of extracellular proteases and the extracellular matrix. Epilepsy Curr (2012) 0.75
The window of epileptogenesis: looking beyond the latent period. Epilepsy Curr (2009) 0.75
Cleaning up epilepsy and neurodegeneration: the role of autophagy in epileptogenesis. Epilepsy Curr (2013) 0.75
Astrocyte networks and epilepsy: when stars collide. Epilepsy Curr (2009) 0.75
Response. J Orthop Sports Phys Ther (2015) 0.75
Traditional Chinese medicine (tongue acupuncture) in children with drooling problems. Pediatr Neurol (2002) 0.75